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Plastic filing from dialysis tubing induces prostanoid release from mac-
rophages. Multiorgan abnormalities in dialysis patients (for example,
hepatosplenomegaly, granulomatous hepatitis, cytopenia from hyper-
splenism) have recently been ascribed to the loading of macrophages
(MØ) with silicone particles released from the pump segment of dial-
ysis tubing. In the present study, the effect of chronic intravenous or
intraperitoneal loading of rats with silicone, polyvinylchloride (PVC)
and polyurethane (PU) particles on arachidonic acid metabolism of
peritoneal MØ and splenic cells was examined in vitro. Intravenous in-
jections of silicone, PVC, or PU particles caused accumulation of the
material within the lysosomes of MØ of spleen, liver, and lung. Spon-
taneous release of prostaglandin E2 (PGE2) and thromboxane B2
(TXB2) was significantly increased in peritoneal MØ of rats injected
with silicone, PVC, or PU (Control: 4.27 0.85 ng PGE2ImII24 hr; sili-
cone 51.9 13.2; PVC 57.5 10.6; PU 28.8 2.3). Zymosan or LPS
stimulated PGE2 release from control MØ, but caused no consistent
further elevation of high basal PGE2 release from MØ after particle
loading. Furthermore, increased spontaneous and stimulated TXB2 re-
lease was also observed in spleen cells of rats given intravenous injec-
tion of silicone particles. It is concluded that storage of plastic parti-
cles (silicone, PVC, and PU) by macrophages stimulates arachidonic
acid metabolism.
La fragmentation du plastigue a partir des tubulures de dialyse induit
le relargage de prostanoides par les macrophages. Des anomalies multi-
organiques chez les dialyses (par exemple, hepatosplenomégalie,
hCpatite granulomateuse, cytopénie par hypersplénisme) ont
récemment ete attribuées a la surcharge des macrophages (Mø) par des
particules de silicone relarguCes a partir du segment siluC au niveau de
Ia pompe des tubulures de dialyse. Dans cette étude, l'effet d'une sur-
charge chronique intraveineuse ou intrapCritonéale de rats avec des
particules de silicone, du chlorure de polyvinyl (PVC), et du
polyurethane (PU) sur Ic mCtabolisme de l'acide arachidonique de MØ
pentonCaux et de cellules splCniques a ete examine in vitro. Les injec-
tions intraveineuses de particules de silicone, de PVC ou de PU ont
entrainC l'accumulation du matériau dans les lysosomes de MØ de rate,
de foie ou de poumon. Le relargage spontané de prostaglandine E2
(PGE2) et de thromboxane B2 (TXB2) était significativement accru dans
les MØ peritonéaux des rats injectés avec le silicone, le PVC ou le PU
(contrôle: 4,27 0,85 ng PGE2Im1/24 hr; silicone 51,9 10,6; PU 28,8
2,3). Le zymosan ou le LPS stimulaient le relargage de PGE2 a par-
tir des MØ contróles, mais n'entrainaient pas d'élCvation
supplémentaire consistante du relargage de PGE2 a un niveau de base
eleve a partir de MØ après surcharge particulaire. En outre, un relarg-
age de TXB2 spontanC et stimulé augmente a aussi etC observe dans
les cellules splCniques de rats ayant recu une injection intraveineuse de
particules de silicone. On conclut que le stockage de particules plas-
tiques (silicone, PVC, et PU) par les macrophages stimule le
mCtabolisme de l'acide arachidonique.
Long-term exposure of dialysis patients to foreign material
has been a constant concern to nephrologists. Despite many
years of observation, only few complications of this kind have
been noted [1—7]. During the last 3 years, several groups [8—12]
have recognized the presence of refractile particles in viscera
of dialysis patients. With energy dispersive x-ray fluorescence
microanalysis, both we [8] and Leong, Disney, and Gove [9]
could demonstrate the element silicon ('4Si) in refractile par-
ticles. It is now agreed that the particles represent silicone fil-
ing shorn off silicone tubing by the action of the roller pump.
Silicone, that is, polydimethylsiloxane, is an inorganic poly-
mer. Several clinical abnormalities have been related to the
loading of macrophages in visceral organs with plastic parti-
cles, for example, elevated transaminases and granulomatous
hepatitis [8—10], hepato- and splenomegaly [8] hypersplenism
with pancytopenia [15], and so forth. In non-dialyzed patients,
lymphoma with silicone inclusions has also been observed in
patients with Swanson-type silicone finger prostheses [16—20].
Changes of current dialysis techniques will be required to
avoid loading of dialysis patients with silicone filing. One pos-
sibility would be the reduction of shearing forces in the roller
pump segment; another would be substitution of silicone by al-
ternate plastic material. To test the safety of potential substi-
tutes for silicone, for example, polyvinylchloride (PVC) or poly-
urethane (PU), these materials were also evaluated in the pres-
ent study.
Because cells of the mononuclear phagocyte system are pre-
dominantly involved in the removal of circulating plastic ma-
terial, we examined whether the function of macrophages is al-
tered after intraperitoneal or intravenous injection of plastic
particles. The present report shows that one important func-
tion of macrophages, that is, release of prostanoids, was stimu-
lated after injection of silicone, PVC, or PU particles.
331
Received for publication October 21, 1983,
and in revised form March 19, 1984
© 1984 by the International Society of Nephrology
332 Bommer et a!
Methods
Animals and experimental protocol
Male Wistar rats, weighing 150 g (Fa. Ivanovas, Kiss-
legg/Allgau), were kept in single cages with free access to food
(Altromin C 1000, Fa. Altromin, Lage/Lippe) and deionized
water. With the use of random numbers, animals were allo-
cated to the control or experimental groups.
In the first series, animals received daily intraperitoneal in-
jections of the solvent (saline) or 2 x 106 particles of silicone,
PVC, or PU suspended in 2 ml pyrogen-free saline. After daily
injections for 5 days, animals were sacrificed 5 days after the
last injection. In the second series, animals received a daily
intravenous injection of either saline (control group) or 2 x 108
particles of silicone, PVC, or PU suspended in 1 ml saline.
Daily injections were given for a total period of 21 days. At in-
tervals, blood samples were taken for transaminases, hemato-
crit, leucocyte, and thrombocyte counts. Determinations were
performed with standard techniques (Technicon Autoanalyzer;
Coulter Counter). Animals were sacrificed 50 days after the last
intravenous injection.
Preparation of plastic particles
Silicone particles were generated by exposing the silicone in-
sert (36 cm) of dialysing tubing (luminal diameter 8 mm; wall
thickness 1.7 mm, Gambro, Lund, Sweden) to a roller pump
(Fresenius Co., Bad Homburg/Ts.) at high occlusion pressure
in a saline primed recirculation system for 24 hr. After 24 hr,
the system was rinsed and the particles were counted in a
counting chamber. Particle size was up to 5 m. Saline was
added to yield the final particle count for injection (2 x 108 per
ml). PVC particles were generated by grinding up 2 x 4 mm
PVC grains (Fa. Rehau, Rehau/Obb.). Grains were suspended
in saline and fragmented in a sterilized commercial whirl mix.
PU particles were generated from polyurethane tubing (lumi-
nal diameter 9 mm; wall thickness 1.2 mm) of Rehau Co.
(Rehau/Obb.) in a recirculation system primed with 20%
ethanol. The tubing was exposed to a roller pump (Fresenius
Co., Bad Homburg/Ts.). After 24 hr, ethanol was evaporated
and particles were suspended in saline. Particle size was up to
5 m.
Saline control fluid for respective experiments was sub-
jected to the same procedure as silicone, PVC, or PU particles
with the exception of roller pump or whirl mix treatment,
respectively.
Preparation of peritoneal macrophages
Macrophages were harvested by peritoneal lavage with sa-
line. Usually, more than 85% of the peritoneal cells were mac-
rophages as evaluated by morphology and phagocytosis of
zymosan or carbon particles [21]. There was no significant in-
crease in the percentage or number of peritoneal macrophages
in animals injected with different plastic particles or saline. Af-
ter washing, macrophages were suspended in serum-free me-
dium RPMI 1640, supplemented with 0.05% lactalbumin, 2 mM
glutamine, 100 IU/ml penicillin, and 100 g/ml streptomycin.
Preparation of spleen cells
The preparation of spleen cells has previously been de-
scribed in detail [22]. Briefly, spleen samples were removed im-
mediately after cardiac exsanguination, dissected free of ad-
herent tissue, cut into small pieces, and macerated gently in a
loosely fitting glass tissue grinder. Tissue remnants were re-
moved by sieving the cells through a small column of nylon fi-
bers (Leukopak, Fenwall Laboratories, Travenol Munchen,
Germany). The spleen cells were washed and transferred into
the RPMI 1640 medium described above.
Culture conditions
Incubations were carried out for 4 or 24 hr at 37°C in tissue
culture plates (3008 MultiWell, Falcon, Oxnard, California), in
which each well contained 1 x 106 macrophages or 3 x 106
spleen cells in 1 ml medium. Where indicated, lipopolysacchar-
ide (LPS) from Escherichia coli 0127 was added at a concen-
tration of 10 ig/ml, zymosan at 20 x 106/ml particles and con-
canavalin A (Con A) at 5 tg/ml. After incubation, the culture
medium was transferred to tubes and centrifuged and the cell-
free supernatants were used for determination of prostanoids.
Radioimmunological determination of prostanoids
The amount of prostaglandin E2 (PGE2) in the culture super-
natants was determined by radioimmunoassay, using a rabbit
antiserum generated against a conjugate of PGE2 with thyro-
globulin as previously outlined [23]. PGE2 determination by ra-
dioimmunoassay followed an established method with dex-
tran-coated charcoal to separate antibody bound from free
PGE2 as previously described in detail [24, 251. The content of
thromboxane B2 (TXB2, metabolite of TXA2) and 6-keto-pros-
taglandin F1 (6-keto-PGF1, metabolite of prostacyclin, PGI2)
in the culture supernatant was determined with a similar
method, employing highly specific antibodies which were
raised in rabbits as outlined previously [25]. All prostanoid
antibodies exhibited less than 0.5% cross-reactivity with other
arachidonic acid derivatives. Quantitative recovery of prosta-
noids added to the incubation medium was determined (90
8%). Immunoreactive prostanoids comigrated with pure refer-
ence prostanoids on thin layer chromatography (silica gel G
1500, 250 m layer, Schleicher and SchUll, Dassel, Germany)
in a solvent consisting of ethyl acetate, isooctane, acetic acid,
and water (11:5:2:10) [26].
Statistics
All values are given as mean SD. Differences between
groups were tested using Wilcoxon test for random samples.
Results
Transaminases, hematological findings, and organ pathology
At the end of the experiment, body weight was identical in
the control group and the corresponding experimental groups
with intraperitoneal or intravenous injection of particles. There
was no evidence of disease in any of the control or experimen-
tal animals. Weight again was continuous in all animals under
study.
Transaminases, hematocrit, leucocyte, and thrombocyte
counts did not differ significantly in control and experimental
animals throughout the experiment. Spleen weight at the end
of the experiment was not significantly different in control and
experimental animals (spleen weight control group: 0.71 0.03
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Fig. 1. Macrophage with polyurethane particle inclusion. The homogeneous amorphous inclusion indicated by the arrows represents polyure-
thane. (Transmission electron microscopy, x 13,000)
g; silicone-injected group: 0.77 0.07 g; PVC-injected group:
0.71 0.03 g; PU-injected group: 0.74 0.07 g; N = 8).
Both after intravenous and intraperitoneal injection of par-
ticles, refractile particles could be demonstrated in macro-
phages by light microscopy. After intraperitoneal injection, this
concerned primarily peritoneal macrophages. After intra-
venous injection, particle-loaded macrophages were noted in
spleen, liver, and lung as well as peritoneal macrophages. The
changes resembled findings previously described by us in pa-
tients dialyzed with silicone tubing [81.
There were no qualitative differences between silicone,
PVC, and PU-treated animals, but the findings varied quanti-
tatively from animal to animal. On transmission electron mi-
croscopy, silicone, PVC, and PU particles were observed
within macrophages and were bounded by lysosomal mem-
branes (Fig. 1).
Effect of intraperitoneal injection of silicone, PVC, nd PU
particles on PGE2 release of peritoneal ,nacrophages
In the peritoneal lavage fluid, the percentage of macro-
phages among the peritoneal cells of control and particle-in-
jected animals was similar. Usually, more than 85% of the cells
were phagocytosing carbon or zymosan particles. Viability of
macrophages as assessed by trypan blue exclusion always ex-
ceeded 90% in all the experiments. In this and the following ex-
periments, a different series of animals were studied, explain-
ing some variance in base-line values. Under in vitro condi-
tions, peritoneal macrophages from rats injected intraperito-
neally with silicone, PVC, or PU released spontaneously more
PGE2 than macrophages from control animals (Table I). This
became apparent after 4 hr (data not given) and was clearly evi-
dent after a 24-hr incubation. Similarly, after in vitro stimula-
tion with zymosan or LPS, peritoneal macrophages of the three
particle-injected groups produced more PGE2 when incubated
for 4 hr (data not given) and particularly when incubated for 24
hr.
Effect of intravenous injection of silicone, PVC, and PU
particles on PGE2 and TXB2 release
from peritoneal macrophages
Both intraperitoneal and intravenous injection of plastic par-
ticles caused enhanced prostanoid release from peritoneal mac-
rophages. Table 1 shows that after 24 hr of incubation, mac-
rophages from silicone, PVC, and PU-injected animals exhib-
ited markedly higher spontaneous PGE2 release than control
cells.
A further difference was noted in that only macrophages
from control animals responded with further PGE2 release
when stimulated with zymosan or LPS. In contrast, macro-
phages from particle-injected rats did not respond to LPS with
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Table 1. Effects of intraperitoneal and intravenous injections respectively of silicone, PVC, and PU particles on spontaneous and stimulated
PGE2 release by macrophagesa
Treatment
of rats
injection
Additions
in vitro
Duration of
incubation
hr
Release of PGE2, ng/ml
Control Silicone PVC PU
Intraperitoneal None
LPS
Zymosan
24
24
24
2.84 0.83
3.74 0.63
6.17 0.99
8.14" 1.57
16.35" 3.46
15.31" 3.22
15.25"
19.14'
18.88"
3.50
2.23
1.92
12.48" 0.64
11.56" 1.02
l4.97b 2.33
Intravenous None
LPS
Zymosan
24
24
24
4.27 0.85
16.90 2.37
21.46 3.15
51.88" 13.18
42.58" 5.30
6.84b 0.72
57.46"
56.52"
24.55
10.61
10.61
4.32
28.75" 2.33
26.16 1.80
5.75" 1.16
a In each group (control, silicone, PVC, and PU), four animals were examined. Macrophages of each animal (I x l0"/ml) were used for four
parallel incubations. The mean of the four incubations was used for the calculation; two separate experiments were made with different groups;
values represent mean SD.
A significant difference (P < 0.05) was noted between control and experimental animals (Wilcoxon test).
Table 2. Effect of intravenous injection of silicone, PVC, or PU particles on spontaneous and stimulated TXB2 release by peritoneal
rnacrophagesa
Additions
Duration of
incubation
hr
Release of TXB2, ng/ml
Control Silicone PVC PU
None
Zymosan
LPS
24
24
24
14.8
93.6
24.0
2.00
14.80
3.20
70.lb 6.48
48.10" 7.0
62.6b 8.0
55.1"
64.1"
66.0"
10.5
15.1
14.4
30.3" 6.2
30.9" 7.0
31.8 6.2
a Please refer to the first footnote of Table I.
b A significant difference (P < 0.05) was noted between control and experimental animals (Wilcoxon test).
24-hr incubation Control Silicone
POE2, ng/ml Basal
Concanavalin A
LPS
4.84 0.56
7.76 1.55
8.99 1.08
16.37"
19.18"
33.24"
2.51
1.95
2.90
TXB2, ng/ml Basal
ConcanavalinA
LPS
2.63 0.96
24.95 4.72
4.43 0.63
13.20"
43.25b
11.48"
3.20
7.69
1.46
further PGE2 release. In response to zymosan, they released
even less POE2 than under basal conditions.
In parallel, macrophages from particle-injected rats sponta-
neously released more TXB2 than control macrophages (Table
2). Whereas in control macrophages stimuli such as zymosan
or LPS further increased TXB2 formation, macrophages of par-
ticle-injected animals remained unresponsive.
The stimulatory effect of concanavalin A on arachidonic acid
metabolism was demonstrated by another experiment shown in
Table 3. This experiment confirms increased spontaneous
PGE2 and TXB2 release from macrophages of silicone-treated
rats and demonstrates in addition the capacity of concanavalin
A to further enhance prostanoid synthesis.
Enhanced TXB2 release from spleen cells
of silicone-treated rats
In addition to peritoneal macrophages, spleen cells compris-
ing both macrophages and lymphatic cells, were studied after
intravenous silicone injection. As shown in Figure 2, in spleen
cells of silicone-treated animals, spontaneous POE2 release
was not different and at best marginally increased after conca-
navalin A and LPS stimulation. However, spontaneous and
concanavalin A or LPS stimulated TXB2 release was markedly
and significantly increased in spleen cells of silicone-treated
animals.
Discussion
The present study clearly demonstrates enhanced arachi-
donic acid metabolism in macrophages of rats which were
chronically exposed to plastic particles by intravenous or in-
traperitoneal injection. A similar increase of TXB2 release was
also observed in spleen cells of rats with chronic administra-
tion of silicone particles by intravenous injection. Increased re-
lease of PGE2 and TXB2 was not only observed after injection
with silicone particles, but also after PVC and PU particles.
It is unlikely that the observed alterations of macrophage
metabolism represent artefacts resulting from infection or non-
specific side effects. The experiments were carried out under
strictly sterile conditions. The experimental animals had nor-
mal behavior, food intake, and growth rates. Furthermore, an
interval of 5 days was interposed between the final intraperi-
toneal injection and harvesting of macrophages to exclude non-
specific effects resulting from the injection procedure. The in-
Table 3. Effect of intravenous injection of silicone particles on
spontaneous and stimulated (concanavalin A, LPS) release of PGE2
and TXB2 by peritoneal macrophagesa
a Please refer to the first footnote of Table 1.
b A significant difference (P < 0.05) was noted between control and
experimental animals (Wilcoxon test).
Fig. 2. Prostaglandin E2 and thromboxane B2
release in spleen cells of rats pretreated with
silicone particles (intravenously),
spontaneously or stimulated by bacterial
lipopolysaccharide or concanavalin A
(incubation 24 hr), respectively.
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terval between the final intravenous injection and the end of the
experiment was 50 days.
With respect to light microscopy and electron microscopy,
the observations in our animals resemble the findings in chroni-
cally dialyzed patients exposed to filing from silicone tubing
[8—12]. Specifically, particles were detectable only in macro-
phages and not as microemboli within capillaries or as inclu-
sions within parenchymatous cells. The plastic particles were
taken up by phagolysosomes and were bounded within
lysosonial membranes. Occasional granuloma formation was
observed in the spleen or liver.
On a quantitative basis, the particle load for dialysis patients
and experimental animals is comparable. During a simulated
dialysis session [27, 28], we showed an in vitro generation of
io particles/ml, equivalent to a total generation of 3 x l0 par-
ticles per 300 ml recirculation fluid. As a consequence, the
number of particles delivered per kilogram of animal body
weight with one injection is comparable to the number of par-
ticles delivered to a dialysis patient during one dialysis
session.
In chronic dialysis patients exposed to silicone particles,
hepatosplenomegaly [13, 14], elevated transaminases [9, 10] or
pancytopenia resulting from hypersplenism [15] are common.
In contrast, none of these changes was observed in the experi-
mental animals, possibly due to the short duration of the
experiment.
Macrophages represent the body's predominant phagocyte
system involved in scavenging foreign particulate material that
is usually degraded or inactivated. The materials used in the
present experiment are nonbiodegradable or at least nonbio-
degraded during the experiment. Based on the analysis of the
size and electron density of phagocytosed particles, Mikuz et
al [29] concluded that silicone was degraded within phagocytes
by an attack of hydrolytic enzymes on the Si-O-Si bonds. How-
ever, other evidence for marked biodegradation by mamma-
han cells has not been reported in literature. From morphologi-
cal studies it is known that inert nonbiodegradable materials ac-
tivate macrophages and may cause granulomatous inflammation.
Peritoneal macrophages were chosen for the present experi-
ments because of their ready availability. Peritoneal macro-
phages contained foreign material even when the latter was in-
jected by the intravenous route. This observation agrees with
previous experimental [30] or clinical [31] findings that silicone
is demonstrable in macrophages throughout the organism after
local administration subcutaneously or at other sites.
Explanted into tissue culture, peritoneal macrophages re-
mained fully viable and displayed functional activities which
they presumably exert in the intact organism. In particular, the
activity of arachidonic acid metabolism can easily be exam-
ined in vitro and may permit conclusions with respect to pros-
tanoid metabolism in vivo. In addition to the peritoneal
macrophage preparation, another uniform cell system with
complex cell interactions, that is, spleen cell suspension, was
examined in the present study.
Among the leucocytic cells, macrophages have been shown
to be the predominant cells species which produces the vari-
ous prostanoids, for example, prostaglandins, thromboxane
and prostacyclin. PGE2 has several biological actions. On the
one hand, it appears to be a pro-inflammatory mediator lead-
ing to vasodilatation and potentiation of edema formation and
pain. On the other hand, it has been shown to be an im-
munosuppressive agent for various lymphocyte functions
[32—34]. The short-lived prostanoid TXA2, assessed by meas-
uring the stable metabolite TXB2, has potent platelet aggregat-
ing properties, whereas the short-lived prostacyclin (PG!2 as-
sessed by measuring the metabolite 6-keto-Fia), has been
shown to inhibit platelet aggregation. Generally, enhanced re-
lease of these compounds points to stimulated macrophage
function [32—34]. The final net biological effect depends on both
the type of prostanoid produced and the presence of appropri-
ate receptor bearing target cells. In the two cell systems used,
for example, peritoneal macrophages and spleen cell suspen-
sions, prostanoid synthesis was stimulated in particle-loaded
animals both under basal conditions and under the influence of
various stimuli. Exceptions to this, for example, diminution of
PGE2 release in response to zymosan (Table 1) may be ex-
plained by our previous observations that highly activated mac-
rophages, when stimulated with zymosan or cytochalasin B,
w
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convert PGE2 to metabolites not detectable with PGE2 antise-
rum [211. No further stimulation of TXB2 formation in macro-
phages of particle-injected animals after exposure to zymosan
or LPS (Table 2) may reflect maximal spontaneous TXB2 re-
lease which cannot be increased further by exogenous stimuli.
Increased prostanoid release by peritoneal macrophages as
an index of macrophage activation is of interest because it dem-
onstrates that cellular storage of plastic particles is not inert
with respect to macrophage function. The mere presence of
foreign material within macrophages in itself, as observed in
organs of dialysis patients, does not necessarily permit the con-
clusion that organ function is deranged. However, the present
demonstration of macrophage activation provides one possible
mechanism for the genesis of pancytopenia in dialysis patients
with hypersplenism [151 or liver dysfunction [8—10]. Further-
more, macrophage activation may also account for the finding
of dense lymphocytic infiltrations around particle-storing mac-
rophages in the liver [10]. Also, macrophage activation may
possibly cause abnormalities of immune function; this ques-
tion was not addressed in the above experiments, but deserves
further examination.
The observation of fever and macrophage-induced organ
damage after exposure to silicone [351 is compatible with pro-
duction of interleukin 1 in humans exposed to excessive sili-
cone. This possibility must be tested by future experiments. It
raises interesting possibilities of interaction, since increased in-
terleukin 1 production from contact with foreign surfaces has
recently been suggested in dialysis patients [36].
Substitution of safe polymers for silicone was considered as
one solution to the problem of silicone elastomer deposition. In
the present study, we failed to observe major differences be-
tween silicone, PVC, and PU with respect to organ histology
or macrophage activation. Consequently, PVC and PU do not
appear to be safe substitutes for silicone tubing. Alternative bio-
engineering solutions must be found to eliminate this compli-
cation [27]. Our recent studies suggest that generation of filing
in the roller pump segment of dialysis machines can be re-
duced by careful adjustment of the distance between roll and
support with an attendant reduction of shearing and flexion
pressures [27, 28].
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